ROTHSCHILD INVESTMENT LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 85338 CHICAGO, IL

Position in REGN

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$728,294

-$419,849 QoQ

Shares Held

1,168

-21.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#720

of 1,327 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ROTHSCHILD INVESTMENT LLC holds $12,549,080 across 228 Biotechnology names. REGN ranks #7 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,038	$2,005,795
2	JAZZ	Jazz Pharmaceuticals plc	6,237	$1,502,929
3	CORT	Corcept Therapeutics Inc	12,195	$1,060,355
4	BMRN	Biomarin Pharmaceutical Inc	15,577	$891,315
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,761	$831,143
6	RVMD	Revolution Medicines, Inc.	3,970	$743,501
7	REGN	Regeneron Pharmaceuticals, Inc. This page	1,168	$728,294
8	EXEL	Exelixis, Inc.	11,735	$638,501

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$728,294	1,168	-21.4%	Shares	Sole	2026-08-06
2026-03-31	$1,148,143	1,486	+52.4%	Shares	Sole	2026-05-07
2025-12-31	$752,573	975	+60.1%	Shares	Sole	2026-02-10
2025-09-30	$342,422	609	+51.1%	Shares	Sole	2025-11-07
2025-06-30	$211,575	403	+0.8%	Shares	Sole	2025-08-11
2025-03-31	$253,692	400	-12.1%	Shares	Sole	2025-04-08
2024-12-31	$324,110	455	-15.7%	Shares	Sole	2025-02-04
2024-09-30	$567,669	540	-9.4%	Shares	Sole	2024-10-18
2024-06-30	$626,413	596	+16.2%	Shares	Sole	2024-07-31
2024-03-31	$493,757	513	+2.4%	Shares	Sole	2024-07-31
2023-12-31	$440,023	501	—	Shares	Sole	2024-07-31
No filing history on record for this holder in this stock.